Related Experiment Video
Updated: Jul 13, 2026

Injection of dsRNA into Female A. aegypti Mosquitos
Published on: July 4, 2007
Amodiaquine-induced hepatitis. A report of seven cases
Abstract:
Seven patients developed hepatitis after receiving amodiaquine for malaria prophylaxis for 4 to 15 weeks. Four patients had a minor form of hepatitis: jaundice was mild or absent, serum aminotransferase levels were moderately increased, and recovery was prompt. Three patients had a severe form: jaundice was intense, serum aminotransferase levels were markedly increased, jaundice persisted for 3 to 6 months, and liver tests were still abnormal 7 to 27 months after the onset of hepatitis. In two patients, serum aminotransferase levels increased promptly after readministration of the drug, which is consistent with an immunoallergic mechanism for amodiaquine-induced hepatitis.
Related Concept Videos
Yellow Fever
Hepatitis
Malaria
Amebiasis
Viral Hepatitis I: Introduction
Hepatic Encephalopathy

